PUBLISHER: KBV Research | PRODUCT CODE: 1245255
PUBLISHER: KBV Research | PRODUCT CODE: 1245255
Europe Cluster Headache Market Size, Share & Industry Trends Analysis Report By Distribution channel, By Type (Episodic, and Chronic), By Drug Class (Triptans, Calcium Channel Blockers, Ergot Derivatives), By Country and Growth Forecast, 2022 - 2028
The Europe Cluster Headache Market would witness market growth of 3.4% CAGR during the forecast period (2022-2028).
Cluster headache signs often appear between the ages of 20 and 40. Researchers traditionally believed that males experienced these headaches more frequently. But now cluster headaches are known to have an equal impact on both men and women. Smokers and heavy drinkers are also more likely to get cluster headaches. Cluster headache sufferers frequently also have sleep apnea. The precise etiology of cluster headaches is still a mystery to specialists. The first branch of the trigeminal nerve and the hypothalamus, a brain component of the autonomic nervous system, is involved in cluster headaches and trigeminal autonomic cephalgia.
In activators of a fresh cycle (round) of headaches most people have cluster headaches infrequently, once per several months or years. The recurrence of headaches frequently seems related to seasonal fluctuations. Many mistakenly believe they have allergies or sinusitis due to the relationship. There may be a connection between cluster headaches and the hypothalamus, as is thought to be the case. The "circadian clock," a built-in timetable that changes in response to sunlight, is located in this brain area.
In Italy, 3.9 million individuals use nicotine more often or for the first time, including through electronic cigarettes. According to the report, one in five people who occasionally use heated tobacco products has switched to regular use, particularly among young people. 3.9 million individuals, or 9% of the population, started using tobacco or increased their use during the lockdown. Of them, 8.5% smoked more cigarettes per day on average, upping their daily intake from 10.9 to 12.7, and most of those who did so were female. These factors driving the region's market growth
The Germany market dominated the Europe Cluster Headache Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $29.1 Million by 2028. The UK market is anticipated to grow at a CAGR of 2.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 4.1% during (2022 - 2028).
Based on Distribution channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Type, the market is segmented Episodic, and Chronic. Based on Drug Class, the market is segmented into Triptans, Calcium Channel Blockers, Ergot Derivatives, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grunenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.
Scope of the Study
Market Segments covered in the Report:
By Distribution channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Others
By Type
- Episodic
- Chronic
By Drug Class
- Triptans
- Calcium Channel Blockers
- Ergot Derivatives
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Dr. Reddy's Laboratories Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Eli Lilly And Company
- Grunenthal GmbH
- Arrotex Pharmaceuticals Pty Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Cluster Headache Market, by Distribution channel
- 1.4.2 Europe Cluster Headache Market, by Type
- 1.4.3 Europe Cluster Headache Market, by Drug Class
- 1.4.4 Europe Cluster Headache Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition & scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Europe Cluster Headache Market by Distribution channel
- 3.1 Europe Drug Stores & Retail Pharmacies Market by Country
- 3.2 Europe Hospital Pharmacies Market by Country
- 3.3 Europe Others Market by Country
Chapter 4. Europe Cluster Headache Market by Type
- 4.1 Europe Episodic Market by Country
- 4.2 Europe Chronic Market by Country
Chapter 5. Europe Cluster Headache Market by Drug Class
- 5.1 Europe Triptans Market by Country
- 5.2 Europe Calcium Channel Blockers Market by Country
- 5.3 Europe Ergot Derivatives Market by Country
- 5.4 Europe Others Market by Country
Chapter 6. Europe Cluster Headache Market by Country
- 6.1 Germany Cluster Headache Market
- 6.1.1 Germany Cluster Headache Market by Distribution channel
- 6.1.2 Germany Cluster Headache Market by Type
- 6.1.3 Germany Cluster Headache Market by Drug Class
- 6.2 UK Cluster Headache Market
- 6.2.1 UK Cluster Headache Market by Distribution channel
- 6.2.2 UK Cluster Headache Market by Type
- 6.2.3 UK Cluster Headache Market by Drug Class
- 6.3 France Cluster Headache Market
- 6.3.1 France Cluster Headache Market by Distribution channel
- 6.3.2 France Cluster Headache Market by Type
- 6.3.3 France Cluster Headache Market by Drug Class
- 6.4 Russia Cluster Headache Market
- 6.4.1 Russia Cluster Headache Market by Distribution channel
- 6.4.2 Russia Cluster Headache Market by Type
- 6.4.3 Russia Cluster Headache Market by Drug Class
- 6.5 Spain Cluster Headache Market
- 6.5.1 Spain Cluster Headache Market by Distribution channel
- 6.5.2 Spain Cluster Headache Market by Type
- 6.5.3 Spain Cluster Headache Market by Drug Class
- 6.6 Italy Cluster Headache Market
- 6.6.1 Italy Cluster Headache Market by Distribution channel
- 6.6.2 Italy Cluster Headache Market by Type
- 6.6.3 Italy Cluster Headache Market by Drug Class
- 6.7 Rest of Europe Cluster Headache Market
- 6.7.1 Rest of Europe Cluster Headache Market by Distribution channel
- 6.7.2 Rest of Europe Cluster Headache Market by Type
- 6.7.3 Rest of Europe Cluster Headache Market by Drug Class
Chapter 7. Company Profiles
- 7.1 Dr. Reddy's Laboratories Ltd.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.2 Novartis AG
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.3 Sun Pharmaceutical Industries Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional & Segmental Analysis
- 7.3.4 Research & Development Expenses
- 7.4 Teva Pharmaceutical Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 GlaxoSmithKline PLC (GSK)
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.6 Pfizer, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional & Segmental Analysis
- 7.6.4 Research & Development Expense
- 7.7 Fresenius SE & Co. KGaA
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.8 Eli Lilly And Company
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.9 Grunenthal GmbH
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.10. Arrotex Pharmaceuticals Pty Limited
- 7.10.1 Company Overview
LIST OF TABLES
- TABLE 1 Europe Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 2 Europe Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 3 Europe Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 4 Europe Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 5 Europe Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
- TABLE 6 Europe Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
- TABLE 7 Europe Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
- TABLE 8 Europe Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
- TABLE 9 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 10 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 11 Europe Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 12 Europe Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 13 Europe Episodic Market by Country, 2018 - 2021, USD Million
- TABLE 14 Europe Episodic Market by Country, 2022 - 2028, USD Million
- TABLE 15 Europe Chronic Market by Country, 2018 - 2021, USD Million
- TABLE 16 Europe Chronic Market by Country, 2022 - 2028, USD Million
- TABLE 17 Europe Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 18 Europe Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 19 Europe Triptans Market by Country, 2018 - 2021, USD Million
- TABLE 20 Europe Triptans Market by Country, 2022 - 2028, USD Million
- TABLE 21 Europe Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
- TABLE 22 Europe Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
- TABLE 23 Europe Ergot Derivatives Market by Country, 2018 - 2021, USD Million
- TABLE 24 Europe Ergot Derivatives Market by Country, 2022 - 2028, USD Million
- TABLE 25 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 26 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 27 Europe Cluster Headache Market by Country, 2018 - 2021, USD Million
- TABLE 28 Europe Cluster Headache Market by Country, 2022 - 2028, USD Million
- TABLE 29 Germany Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 30 Germany Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 31 Germany Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 32 Germany Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 33 Germany Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 34 Germany Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 35 Germany Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 36 Germany Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 37 UK Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 38 UK Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 39 UK Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 40 UK Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 41 UK Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 42 UK Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 43 UK Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 44 UK Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 45 France Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 46 France Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 47 France Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 48 France Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 49 France Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 50 France Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 51 France Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 52 France Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 53 Russia Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 54 Russia Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 55 Russia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 56 Russia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 57 Russia Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 58 Russia Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 59 Russia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 60 Russia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 61 Spain Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 62 Spain Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 63 Spain Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 64 Spain Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 65 Spain Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 66 Spain Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 67 Spain Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 68 Spain Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 69 Italy Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 70 Italy Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 71 Italy Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 72 Italy Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 73 Italy Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 74 Italy Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 75 Italy Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 76 Italy Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 77 Rest of Europe Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 78 Rest of Europe Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 79 Rest of Europe Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 80 Rest of Europe Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 81 Rest of Europe Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 82 Rest of Europe Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 83 Rest of Europe Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 84 Rest of Europe Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 85 key information - Dr. Reddy's Laboratories Ltd.
- TABLE 86 Key Information - Novartis AG
- TABLE 87 Key Information - Sun Pharmaceutical Industries Ltd.
- TABLE 88 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 89 Key Information - GlaxoSmithKline PLC (GSK)
- TABLE 90 Key Information - Pfizer, Inc.
- TABLE 91 key information - Fresenius SE & Co. KGaA
- TABLE 92 Key Information - Eli Lilly And Company
- TABLE 93 Key Information - Grunenthal GmbH
- TABLE 94 Key Information - Arrotex Pharmaceuticals Pty Limited
List of Figures
- FIG 1 Methodology for the research
